Vedolizumab for induction and maintenance of remission in Crohn’s disease
Samuel Hui, Anuj Krishna, Nik S. Ding, Ray Boyapati
Abstract
Samuel Hui, Anuj Krishna, Nik S. Ding, Ray Boyapati
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The primary objective of this systematic review of the literature is to assess the efficacy and safety of vedolizumab in the induction and maintenance of remission in Crohn's disease.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: The primary objective of this systematic review of the literature is to assess the efficacy and safety of vedolizumab in the induction and maintenance of remission in Crohn's disease.
Key concepts: Vedolizumab, Crohn's disease, Medicine, Maintenance therapy, Disease, Intervention (counseling), Internal medicine, Intensive care medicine